WO2003031981A3 - Kit for predicting binding of a specific antibody to a potential immunogen and method of screening - Google Patents

Kit for predicting binding of a specific antibody to a potential immunogen and method of screening Download PDF

Info

Publication number
WO2003031981A3
WO2003031981A3 PCT/DK2002/000665 DK0200665W WO03031981A3 WO 2003031981 A3 WO2003031981 A3 WO 2003031981A3 DK 0200665 W DK0200665 W DK 0200665W WO 03031981 A3 WO03031981 A3 WO 03031981A3
Authority
WO
WIPO (PCT)
Prior art keywords
kit
screening
specific antibody
predicting binding
binding
Prior art date
Application number
PCT/DK2002/000665
Other languages
French (fr)
Other versions
WO2003031981A2 (en
Inventor
Erwin Ludo Roggen
Nina Teeres Nilsson
Steffen Ernst
Shamkant Anant Patkar
Esben Peter Friis
Original Assignee
Novozymes As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novozymes As filed Critical Novozymes As
Priority to EP02800546A priority Critical patent/EP1436627A2/en
Priority to CA002462651A priority patent/CA2462651A1/en
Publication of WO2003031981A2 publication Critical patent/WO2003031981A2/en
Publication of WO2003031981A3 publication Critical patent/WO2003031981A3/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2299/00—Coordinates from 3D structures of peptides, e.g. proteins or enzymes

Abstract

A kit is disclosed for predicting binding of specific antibodies to potential immunogens. The kit comprises antigenic peptide sequences having less than 26 amino acids, said antigenic peptide sequences being capable of binding antibodies specific for structural epitopes con-tained on potential immunogens. The antigenic peptide sequences are immobilized on a solid support.
PCT/DK2002/000665 2001-10-05 2002-10-04 Kit for predicting binding of a specific antibody to a potential immunogen and method of screening WO2003031981A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP02800546A EP1436627A2 (en) 2001-10-05 2002-10-04 Kit for predicting binding of a specific antibody to a potential immunogen and method of screening
CA002462651A CA2462651A1 (en) 2001-10-05 2002-10-04 Kit for predicting binding of a specific antibody to a potential immunogen and method of screening

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200101473 2001-10-05
DKPA200101473 2001-10-05

Publications (2)

Publication Number Publication Date
WO2003031981A2 WO2003031981A2 (en) 2003-04-17
WO2003031981A3 true WO2003031981A3 (en) 2004-03-04

Family

ID=8160753

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DK2002/000665 WO2003031981A2 (en) 2001-10-05 2002-10-04 Kit for predicting binding of a specific antibody to a potential immunogen and method of screening

Country Status (3)

Country Link
EP (1) EP1436627A2 (en)
CA (1) CA2462651A1 (en)
WO (1) WO2003031981A2 (en)

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5196510A (en) * 1988-12-29 1993-03-23 Cytogen Corporation Molecular recognition units
WO1996023873A1 (en) * 1995-02-03 1996-08-08 Novo Nordisk A/S Amylase variants
US5891640A (en) * 1992-03-06 1999-04-06 N.V. Innogenetics S.A. Peptide derived from human immunodeficiency virus type 1 (HIV-1), isolate ant70, containing an immunodominant epitope and it's use in immunodiagnostic assays
WO1999047680A1 (en) * 1998-03-16 1999-09-23 Alk-Abelló A/S Mutant recombinant allergens
WO2000026230A1 (en) * 1998-10-30 2000-05-11 Novozymes A/S Low allergenic protein variants
WO2000032626A1 (en) * 1998-11-25 2000-06-08 Regents Of The University Of Minnesota Methods of using epitope peptides of human pathogens
US6210901B1 (en) * 1994-01-31 2001-04-03 Roche Diagnostics Gmbh Specific binding substances for antibodies and their use for immunoassays or vaccines

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5196510A (en) * 1988-12-29 1993-03-23 Cytogen Corporation Molecular recognition units
US5891640A (en) * 1992-03-06 1999-04-06 N.V. Innogenetics S.A. Peptide derived from human immunodeficiency virus type 1 (HIV-1), isolate ant70, containing an immunodominant epitope and it's use in immunodiagnostic assays
US6210901B1 (en) * 1994-01-31 2001-04-03 Roche Diagnostics Gmbh Specific binding substances for antibodies and their use for immunoassays or vaccines
WO1996023873A1 (en) * 1995-02-03 1996-08-08 Novo Nordisk A/S Amylase variants
WO1999047680A1 (en) * 1998-03-16 1999-09-23 Alk-Abelló A/S Mutant recombinant allergens
WO2000026230A1 (en) * 1998-10-30 2000-05-11 Novozymes A/S Low allergenic protein variants
WO2000032626A1 (en) * 1998-11-25 2000-06-08 Regents Of The University Of Minnesota Methods of using epitope peptides of human pathogens

Also Published As

Publication number Publication date
WO2003031981A2 (en) 2003-04-17
CA2462651A1 (en) 2003-04-17
EP1436627A2 (en) 2004-07-14

Similar Documents

Publication Publication Date Title
WO2002085926A3 (en) Method for producing stable, regeneratable antibody arrays
ES2121400T3 (en) CELL SELECTION POSITIVE AND POSITIVE / NEGATIVE MEDIATED BY RELEASE WITH PEPTIDES.
AU8432498A (en) Human-cd28 specific monoclonal antibodies for antigen non-specific activation oft-lymphocytes
WO2003029458A3 (en) Method for producing protein libraries and for selecting proteins from said libraries
HUP0200265A2 (en) Hiv peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by hiv
WO1998027114A3 (en) Mammalian cell surface antigens; related reagents
TW200516083A (en) Methods for making dual specificity antibodies
CA2348379A1 (en) Immunoassay for measuring human c-peptide and kit therefor
WO2003087129A3 (en) Immunogenic peptides, and method of identifying same
AU2002349344A1 (en) Microfluidic extraction method
EP1114864A3 (en) Mammalian cell surface antigens, related reagents
AU6618100A (en) Monoclonal antibodies to tacrolimus and immunoassay methods for tacrolimus
WO2003045975A3 (en) Solid-phase immobilization of proteins and peptides
AU5686698A (en) Methods for the production of chicken monoclonal antibodies
IL154000A (en) Method employing antibodies for diagnosing rheumatoid arthritis
DK1167389T3 (en) Antibodies to the SEMP1 protein, method of preparation thereof, and use thereof
AU7960600A (en) Monoclonal antibody, hybridoma, immunoassay method and diagnosis kit
WO1999013907A3 (en) Methods to improve immunogenicity of antigens and specificity of antibodies
WO2002036738A3 (en) Affinity maturation by competitive selection
WO2003018797A3 (en) Method and device for integrated protein expression, purification and detection
WO2003031981A3 (en) Kit for predicting binding of a specific antibody to a potential immunogen and method of screening
EP1094080A3 (en) Anti-dnase-gamma antibody, and production and use thereof
WO2005121178A3 (en) Immunoaffinity chromatography polyol-responsive monoclonal antibodies
AU2001276916A1 (en) Labeled peptides, proteins and antibodies and processes and intermediates useful for their preparation
WO2001051926A3 (en) Competitive enzyme immunoassay for assessing total antigen content of aluminum-adsorbed antigens

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ OM PH PL PT RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG UZ VC VN YU ZA ZM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2462651

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2002800546

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2002333222

Country of ref document: AU

WWP Wipo information: published in national office

Ref document number: 2002800546

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP